Epstein Secrets

t. On NBC Nightly News <https://playvideo.bulletinintelligence.corn/ed6acbba7a9f4e498e804748dcd439bf?pubid=fbi> (8/24, story 7, 2:45, Holt, 6.03M), Tom Costello reported that "infectious disease experts [are] cautious and divided about convalescent plasma. Just last week, NIH Director Collins, [NIAID Directo

d designing an engaged functional organizational structure, will be the catalyst for the significant improvements in cost, performance and growth." Geoff Bennett of NBC Nightly News EFTA00136549 <https://playvideo.bulletinintelligence.com/fa3ae70660844cff9a5ac99c7caaa54b?pubid=fbi> (8/24, story 9, 1:40, Ho

On NBC Nightly News <https://playvideo.bulletinintelligence.com/f62391a9f8364a03a0248276978 I beaa? pubid=fbi> (11/23, story 4, 1:40, Holt, 6.28M), Tom Costello reported, "With multiple vaccines potentially on the way, health experts must now convince Americans they're safe. After the White House interfered

" On NBC Nightly News <https://playvideo.bulletinintelligence.com/8660ad711aea4f409dfff6eal0d318e9? pubid=fbi> (11/23, story 2, 1:45, Holt, 6.28M), Geoff Bennett said that after four years of President Trump "often at odds with the foreign policy establishment," Biden "is pulling from that group for his first

e chief pharmacy officer here tells me they can be ready by tomorrow if they need to be." On NBC Nightly NewsVi (11/23, story 4, 1:40, Holt, 6.28M), Tom Costello reported, "With multiple vaccines potentially on the way, health experts must now convince Americans they're safe. After the White House interfered

and signal that Biden intends to show the world a different face after the Trump years." On NBC Nightly NewsVi (11/23, story 2, 1:45, Holt, 6.28M), Geoff Bennett said that after four years of President Trump "often at odds with the foreign policy establishment," Biden "is pulling from that group for his firs

" Two of the three networks reported Monday night on the FDA's approval of the treatment. On NBC Nightly NewsVi (8/24, story 7, 2:45, Holt, 6.03M), Tom Costello reported that "infectious disease experts [are) cautious and divided about convalescent plasma. Just last week, NIH Director Collins, [NIAID Direct

designing an engaged functional organizational structure, will be the catalyst for the significant improvements in cost, performance and growth." Geoff Bennett of NBC Nightly NewsVi (8/24, story 9, 1:40, Holt, 6.03M) said DeJoy was "on defense" as he faced "scathing criticism," and USA Today (8/24, Hayes, W

" Two of the three networks reported Monday night on the FDA's approval of the treatment. On NBC Nightly NewsVi (8/24, story 7, 2:45, Holt, 6.03M), Tom Costello reported that "infectious disease experts [are) cautious and divided about convalescent plasma. Just last week, NIH Director Collins, [NIAID Direct

designing an engaged functional organizational structure, will be the catalyst for the significant improvements in cost, performance and growth." Geoff Bennett of NBC Nightly NewsVi (8/24, story 9, 1:40, Holt, 6.03M) said DeJoy was "on defense" as he faced "scathing criticism," and USA Today (8/24, Hayes, W